Literature DB >> 20308006

Primary tumor induces sentinel lymph node lymphangiogenesis in oral squamous cell carcinoma.

Hiroki Ishii1, Kazuaki Chikamatsu, Koichi Sakakura, Masanori Miyata, Nobuhiko Furuya, Keisuke Masuyama.   

Abstract

The main factor that affects the prognosis of patients with oral squamous cell carcinoma (OSCC) is regional lymph node metastases, which usually spreads first to the sentinel lymph nodes (SLNs). Recent studies have demonstrated that tumor cells in several malignancies can induce lymphangiogenesis in SLNs before metastasizing. To elucidate the mechanisms of tumor dissemination of OSCC, we investigated whether primary tumors induce lymphangiogenesis within SLNs in patients with OSCC. The mRNA expression of lymphatic-specific markers, including VEGFR-3, Prox-1, and LYVE-1 in 23 metastasis-negative SLNs obtained from 10 patients with OSCC, was investigated using a quantitative real-time RT-PCR assay, and compared with control lymph nodes from patients with non-cancerous diseases. In addition, VEGF-C and VEGF-D expressions of the primary tumor were examined by immunohistochemistry. In SLNs, there were highly significant correlations between the three lymphatic markers examined. Interestingly, the level of LYVE-1 expression in SLNs, despite the absence of metastasis, was significantly higher than in control lymph nodes. Moreover, SLNs from patients with VEGF-C-positive tumor showed a significantly higher expression of VEGFR-3 than those from patients with VEGF-C-negative tumor. Our findings suggest that in OSCC, the primary tumor actively induces lymphangiogenesis in SLNs prior to the onset of metastases, and where tumor-derived VEGF-C plays an important role. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20308006     DOI: 10.1016/j.oraloncology.2010.02.014

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  18 in total

1.  Interval sentinel lymph nodes in melanoma: a digital pathology analysis of Ki67 expression and microvascular density.

Authors:  Christian Marinaccio; Giuseppe Giudice; Eleonora Nacchiero; Fabio Robusto; Giuseppina Opinto; Gaetano Lastilla; Eugenio Maiorano; Domenico Ribatti
Journal:  Clin Exp Med       Date:  2015-08-15       Impact factor: 3.984

2.  Imaging tumor-induced sentinel lymph node lymphangiogenesis with LyP-1 peptide.

Authors:  Fan Zhang; Gang Niu; Xin Lin; Orit Jacobson; Ying Ma; Henry S Eden; Yulong He; Guangming Lu; Xiaoyuan Chen
Journal:  Amino Acids       Date:  2011-07-19       Impact factor: 3.520

3.  A specific immune and lymphatic profile characterizes the pre-metastatic state of the sentinel lymph node in patients with early cervical cancer.

Authors:  Cédric Balsat; Silvia Blacher; Michael Herfs; Maureen Van de Velde; Nicolas Signolle; Philippe Sauthier; Charles Pottier; Stéphanie Gofflot; Marjolein De Cuypere; Philippe Delvenne; Frédéric Goffin; Agnès Noel; Frédéric Kridelka
Journal:  Oncoimmunology       Date:  2017-02-10       Impact factor: 8.110

4.  Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms.

Authors:  Hiroki Ishii; Masao Saitoh; Kei Sakamoto; Tetsuo Kondo; Ryohei Katoh; Shota Tanaka; Mitsuyoshi Motizuki; Keisuke Masuyama; Keiji Miyazawa
Journal:  J Biol Chem       Date:  2014-08-20       Impact factor: 5.157

Review 5.  Opposing Roles of Vascular Endothelial Growth Factor C in Metastatic Dissemination and Resistance to Radio/Chemotherapy: Discussion of Mechanisms and Therapeutic Strategies.

Authors:  Christopher Montemagno; Frédéric Luciano; Gilles Pagès
Journal:  Methods Mol Biol       Date:  2022

6.  Lymphatic Vessel Density and Vascular Endothelial Growth Factor Expression in Squamous Cell Carcinomas of Lip and Oral Cavity: A Clinicopathological Analysis with Immunohistochemistry Using Antibodies to D2-40, VEGF-C and VEGF-D.

Authors:  Soh Watanabe; Masako Kato; Isamu Kotani; Kazuo Ryoke; Kazuhiko Hayashi
Journal:  Yonago Acta Med       Date:  2013-03-01       Impact factor: 1.641

7.  Tumor-derived VEGF-C, but not VEGF-D, promotes sentinel lymph node lymphangiogenesis prior to metastasis in breast cancer patients.

Authors:  Ying-Chun Zhao; Xiao-Jian Ni; Ming-Hai Wang; Xiao-Ming Zha; Yi Zhao; Shui Wang
Journal:  Med Oncol       Date:  2012-05-06       Impact factor: 3.064

8.  Lymphangiogenesis in regional lymph nodes is an independent prognostic marker in rectal cancer patients after neoadjuvant treatment.

Authors:  Christiane Jakob; Daniela E Aust; Birgit Liebscher; Gustavo B Baretton; Kaustubh Datta; Michael H Muders
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

9.  Tumor lymphangiogenesis as a potential therapeutic target.

Authors:  Tam Duong; Peter Koopman; Mathias Francois
Journal:  J Oncol       Date:  2012-02-16       Impact factor: 4.375

10.  Establishment and characterization of a novel lymphangiosarcoma cell line (MO-LAS) compared with the hemangiosarcoma cell line (ISO-HAS).

Authors:  Mikio Masuzawa; Mamiko Masuzawa; Yuhko Hamada; Nobuko Arakawa; Mari Mori; Masako Ishii; Shigeo Nishiyama
Journal:  Cancer Med       Date:  2012-07-13       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.